Recent Updates
Recently added Catalysts
IRON Negative Sentiment Score: 20/100

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Key Takeaway: The Rosen Law Firm is investigating potential securities claims for shareholders of Disc Medicine, Inc. (NASDAQ: IRON) due to allegations of misleading business information. A Complete Response Letter from the FDA rejected the company's new drug application, causing a 22% drop in the stock price. Investors who purchased securities may be entitled to compensation through a class action lawsuit, with no upfront costs. The firm encourages investors to consult experienced legal counsel for such matters.

Market Sentiment Analysis

CONCERNS & RISKS

  • Disc Medicine faced a significant stock price drop of 22% following the FDA's Complete Response Letter.
  • The FDA's letter indicated that there were uncertainties in the new drug application that could not be resolved.
  • Allegations have surfaced regarding potentially misleading information being issued by Disc Medicine to investors.

Full Press Release Details

NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=56641 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
WHAT IS THIS ABOUT: On February 13, 2026, the U.S. Food and Drug Administration (“FDA”) issued a Complete Response Letter (“CRL”) to Disc Medicine regarding its bitopertin program. The FDA stated they could not approve Disc Medicine’s new drug application (“NDA”) as there were uncertainties in the NDA that would need additional evidence.
On this news, Disc Medicine’s stock price fell 22% on February 13, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
Toll Free: (866) 767-3653

Tags

Frequently Asked Questions

What is the investigation by Rosen Law Firm about?

Rosen Law Firm is investigating potential securities claims against Disc Medicine due to allegations of misleading business information.

How can shareholders of Disc Medicine participate in the class action?

Shareholders can join the class action by visiting the provided website or contacting Phillip Kim, Esq.

What triggered the drop in Disc Medicine's stock price?

The stock price fell 22% after the FDA issued a Complete Response Letter regarding its NDA.

Why should investors choose Rosen Law Firm?

Rosen Law Firm has a strong track record in securities class actions and has recovered significant amounts for investors.

Last updated: Jun 21, 2026